tiprankstipranks
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns
PremiumCompany AnnouncementsKala Pharmaceuticals Board Member Mark Blumenkranz Resigns
5M ago
Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
Premium
The Fly
Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
6M ago
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
Premium
The Fly
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
7M ago
Kala Pharmaceuticals reports Q1 EPS ($4.20), consensus ($(2.89)
PremiumThe FlyKala Pharmaceuticals reports Q1 EPS ($4.20), consensus ($(2.89)
9M ago
Kala Pharmaceuticals price target lowered to $21 from $22 at H.C. Wainwright
Premium
The Fly
Kala Pharmaceuticals price target lowered to $21 from $22 at H.C. Wainwright
11M ago
KALA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KALA Earnings this Week: How Will it Perform?
11M ago
Kala Pharmaceuticals price target lowered to $22 from $39 at Wedbush
PremiumThe FlyKala Pharmaceuticals price target lowered to $22 from $39 at Wedbush
1y ago
Kala Pharmaceuticals reports Q2 EPS ($3.41), consensus ($2.15)
Premium
The Fly
Kala Pharmaceuticals reports Q2 EPS ($3.41), consensus ($2.15)
1y ago
Kala Pharmaceuticals reports Q2 EPS ($4.36), consensus ($3.19)
Premium
The Fly
Kala Pharmaceuticals reports Q2 EPS ($4.36), consensus ($3.19)
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100